key: cord-0929698-z45s5hbc authors: Li, Gang title: Glucocorticoid, Covid-19, bone and nerve repair date: 2021-12-22 journal: J Orthop Translat DOI: 10.1016/j.jot.2021.11.011 sha: 189019d0e08ea237b1cca31e97730b1d08d2a606 doc_id: 929698 cord_uid: z45s5hbc nan COVID-19 was first identified and breakout in the Chinese city Wuhan in early 2020, and glucocorticoids was one of the therapies for severe Covid-19 cases. What is the incident rate for glucocorticoids-induced osteonecrosis for Covid-19 patients? A systematic review of glucocorticoid associated osteonecrosis and an investigation of glucocorticoid exposure of COVID-19 patients in Wuhan city were conducted. The average of cumulative glucocorticoid (methylprednisolone) exposure was 504 mg for the Covid-19 patients and only 1 confirmed osteonecrosis case was identified out of 1406 patients with glucocorticoid treatment in this cohort of Wuhan patients, implying the importance of early prevention of glucocorticoids-induced osteonecrosis with patient screening and preventive measurements [1] . For challenging formal head osteonecrosis management, there are many new attempts published in recent 2 years in this Journal [2] [3] [4] [5] [6] [7] . In this issue Li et al. reported a novel scaffold carrying vascular bundle for the treatment of necrotic femoral head following decompression, they have also anastomosed the transplanted vascular bundles with the existing blood vessels around the hip, which significantly improved the treatment successful rate [8] . Continues understanding the mechanisms of bone repair will lead to novel and more efficient therapy. Journal of Orthopaedic Translation has published many innovative discoveries focusing on new technologies in the past 2 years [9] [10] [11] [12] [13] [14] [15] . In this issue, Wang et al. reported that transient activation of notch signaling by Jagged-1 peptide significantly enhanced mesenchymal stem cell proliferation in the bone marrow and promoted bone defect repair [16] . Of course, bone regeneration is closely associated with vascularization, therapeutic agents that stimulate angiogenesis will greatly benefit bone repair. When plant-derived Cucurbitacin B was incorporated into PLGA andβ-TCP scaffolds, they significantly enhanced neovascularization and bone formation in rat critical calvarial defect model [17] . Neve injury repair still remains as one of the most challenging orthopaedic issues. Clearance of myelin debris and remyelination are necessary steps for peripheral nerve regeneration, yet these processes are not well understood. Shi et al. screened the difference in genes of normal and activated Schwann cells harvested before and following peripheral nerve injury, and found that core genes in endocytosis pathway were highly activated following nerve injury, suggesting enhancing endocytosis may be a new therapeutic strategy for nerve tissue engineering [18] . Spinal cord injury (SCI) is a disastrous situation that affects many patients worldwide, yet the treatment options remain to be limited. Following the publication of clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019) in our journal in 2020 [19] , we have published many original and cutting edge research work in SCI pathogenesis and treatment [20] [21] [22] . Among the many new targets, exosomes emerge to be a potential treatment option for SCI. Exosomes are complex lipid membrane structures secreted by cells, can transport their cargoes (proteins, microRNAs) to the targeted cells and exert their communication and regulation functions. Pan et al. have reviewed and discussed the use of various stem cells derived exosomes for the treatment of SCI [23] . Despite the long-lasting Covid-10 pandemic struggle, academics around the world are working tirelessly to provide education and service [24] , discover new biological mechanisms in musculoskeletal tissue regeneration. New inventions continue to emerge to help building better bones and nerves. With combined endeavors, we shall overcome Covid-19 soon and be even stronger in body and mind! General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19 Effect of porosity of a functionallygraded scaffold for the treatment of corticosteroid-associated osteonecrosis of the femoral head in rabbits Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model Gastrin for prevention of steroid-associated osteonecrosis in rats Chinese herbal Huo-Gu Formula for treatment of steroid-associated osteonecrosis of femoral head: a 14-years follow-up of convalescent SARS patients Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version) Huo Xue Tong Luo capsule, a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head: a prospective study A novel device for treatment of osteonecrosis of femoral head: feasibility and preliminary efficacy of animal study The effect of traumatic brain injury on bone healing from a novel exosome centered perspective in a mice model Cheung Wing Hoi. The role of osteocytes-specific molecular mechanism in regulation of mechanotransduction -a systematic review Differential gene expression profile by RNA sequencing study of elderly osteoporotic hip fracture patients with sarcopenia Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis The effect of topical administration of simvastatin on entochondrostosis and intramembranous ossification: an animal experiment Cyasterone accelerates fracture healing by promoting MSCs migration and osteogenesis Deosteogenic-differentiated mesenchymal stem cells accelerate fracture healing by mir-92b Transient activation of notch signaling enhances endogenous stromal cell expansion and subsequent bone defect repair PLGA/β-TCP composite scaffold incorporating cucurbitacin B promotes bone regeneration by inducing angiogenesis Endocytosis-associated patterns in nerve regeneration after peripheral nerve injury Clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019) The emerging role of circular RNAs in spinal cord injury Unilateral cervical spinal cord injury induces bone loss and metabolic changes in non-human primates (Macaca fascicularis) Neurotropin exerts neuroprotective effects after spinal cord injury by inhibiting apoptosis and modulating cytokines Potential of different cells-derived exosomal microRNA cargos for treating spinal cord injury Impact of COVID-19 on orthopaedic clinical service